JAZZ vs PETS · P/E 1988, rev $4.07B vs rev $227.0M
Jazz Pharmaceuticals PLC (JAZZ) versus PetMed Express Inc (PETS) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
PetMed Express Inc (PETS) is a pharmaceutical retailers company listed on NASDAQ.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported PETS revenue for 2025-03-31 was $227.0M. Net income was -$6.3M. PETS currently screens at market cap $38.5M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. PETS currently screens at market cap $38.5M.
Not investment advice. Open the JAZZ and PETS stock pages for the full models.
Not investment advice.